Suppr超能文献

用于检测阻塞性睡眠呼吸暂停和心律失常的多诊断胸部贴片

Multidiagnostic chest-worn patch to detect obstructive sleep apnea and cardiac arrhythmias.

作者信息

Goldstein Cathy, Ghanbari Hamid, Sharma Surina, Collop Nancy, Loring Zak, Walsh Colleen, Torstrick Brennan, Herreshoff Emily, Pollock Mark, Frankel David S, Rosen Ilene M

机构信息

Department of Neurology, University of Michigan, Ann Arbor, Michigan.

Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan.

出版信息

J Clin Sleep Med. 2025 May 1;21(5):855-866. doi: 10.5664/jcsm.11522.

Abstract

STUDY OBJECTIVES

Evaluate the performance of the SANSA device to simultaneously assess obstructive sleep apnea and cardiac arrhythmias.

METHODS

Participants suspected or known to have obstructive sleep apnea underwent polysomnography while wearing SANSA. SANSA's algorithm was trained using 86 records and tested on 67 to evaluate training bias. SANSA performance was evaluated against ground truth polysomnography scored by the consensus of 3 technologists. Polysomnography scoring from individual testing sites was also evaluated against consensus. Diagnostic performance was evaluated using standard apnea-hypopnea index cutoffs. Apnea-hypopnea index and total sleep time agreement was analyzed using correlation and Bland-Altman plots. Electrocardiogram was reviewed for presence of significant arrhythmias (frequent premature atrial/ventricular complexes and atrial fibrillation).

RESULTS

SANSA's sensitivity and specificity to detect obstructive sleep apnea ranged from 91-97% and 78-97%, respectively, across all severity levels. SANSA total sleep time correlation with consensus polysomnography total sleep time was 0.83 with a mean difference of 3.8 minutes (limits of agreement: -91.1 to 98.7). Significant arrhythmias were detected in 32% of participants. These participants had a greater apnea-hypopnea index (27.5 vs 15.8 events/h, = .003) and spent nearly twice as long at reduced oxygenation levels (47.5 vs 20.5 minutes under 88% oxygen saturation, = .009).

CONCLUSIONS

SANSA is a promising tool for comprehensive obstructive sleep apnea evaluation, offering the unique advantage of concurrent arrhythmia detection. This dual functionality may improve patient outcomes through early diagnosis and management of both conditions.

CITATION

Goldstein C, Ghanbari H, Sharma S, et al. Multidiagnostic chest-worn patch to detect obstructive sleep apnea and cardiac arrhythmias. . 2025;21(5):855-866.

摘要

研究目的

评估SANSA设备同时评估阻塞性睡眠呼吸暂停和心律失常的性能。

方法

疑似或已知患有阻塞性睡眠呼吸暂停的参与者在佩戴SANSA时接受多导睡眠图检查。SANSA的算法使用86份记录进行训练,并在67份记录上进行测试以评估训练偏差。将SANSA的性能与由3名技术人员达成共识评分的地面真值多导睡眠图进行比较。还将各个测试地点的多导睡眠图评分与共识评分进行比较。使用标准呼吸暂停低通气指数临界值评估诊断性能。使用相关性和布兰德-奥特曼图分析呼吸暂停低通气指数和总睡眠时间的一致性。检查心电图是否存在显著心律失常(频繁的房性/室性早搏和心房颤动)。

结果

在所有严重程度水平上,SANSA检测阻塞性睡眠呼吸暂停的敏感性和特异性分别为91%-97%和78%-97%。SANSA总睡眠时间与共识多导睡眠图总睡眠时间的相关性为0.83,平均差异为3.8分钟(一致性界限:-91.1至98.7)。32%的参与者检测到显著心律失常。这些参与者的呼吸暂停低通气指数更高(27.5次/小时对15.8次/小时,P = 0.003),并且在低氧水平下花费的时间几乎是前者的两倍(氧饱和度低于88%时为47.5分钟对20.5分钟,P = 0.009)。

结论

SANSA是一种用于全面评估阻塞性睡眠呼吸暂停的有前景的工具,具有同时检测心律失常的独特优势。这种双重功能可能通过对两种疾病的早期诊断和管理来改善患者的治疗效果。

引用文献

Goldstein C, Ghanbari H, Sharma S,等。用于检测阻塞性睡眠呼吸暂停和心律失常的多诊断胸部贴片。……2025;21(5):855 - 866。

相似文献

本文引用的文献

2
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity.替尔泊肽治疗阻塞性睡眠呼吸暂停和肥胖。
N Engl J Med. 2024 Oct 3;391(13):1193-1205. doi: 10.1056/NEJMoa2404881. Epub 2024 Jun 21.
10
Bidirectional relationships of comorbidity with obstructive sleep apnoea.共病与阻塞性睡眠呼吸暂停的双向关系。
Eur Respir Rev. 2022 May 4;31(164). doi: 10.1183/16000617.0256-2021. Print 2022 Jun 30.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验